Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
29 August 2025 | Story Igno van Niekerk | Photo Stephen Collett
One-Room Space
The UFS’ one-room spaces are designed to connect students and lecturers seamlessly across locations and borders.

The university is transforming education across its Bloemfontein, Qwaqwa, and South campuses with its pioneering one-room spaces, mirrored across all three locations to deliver cutting-edge, immersive learning. Research for these innovative spaces began in 2023, sparked by a photo from the University of Leuven in Belgium, which the university identified as showcasing Leuven’s advanced classroom setup. Prof Philippe Burger, Dean of the Faculty of Economic and Management Sciences, leveraging a connection there, led a team to explore this technology globally, collaborating with Canada’s X2O OneRoom to make the UFS the first in South Africa – and one of (as far as we know) two in Africa, alongside Kenya – to offer such immersive classrooms.

Unlike Zoom or Blackboard, where online students were often overlooked as small icons, one-room spaces ensure that everyone feels included. Designed for postgraduate training and PhD interactions, these rooms accommodate up to 40 in-person and 40 online participants, with large video camera feeds on screens, reminiscent of the TV programme Small Talk, where children’s faces lined the wall for engagement. Directional audio and personal cameras create a sensory experience, with sound coming from the speaker’s direction and eye contact feeling natural. Angelique Carson-Porter from the Department of Nutrition and Dietetics shared her excitement about a postgraduate session led by Prof Aletta Olivier, Lecturer in the Centre for Gender and Africa Studies: “It feels like you’re right there, even from Pretoria or Ghana. You see everyone, interact, and never miss a beat.”

Gavin Coetzer at ICT Services, a key project leader, highlighted how lecturers struggled with older platforms’ limitations, often only addressing online questions at the end, disrupting the flow. The UFS’ one-room spaces, implemented in the UFS Business School, the Clinical Skills Unit, South Campus teacher training, and Qwaqwa, solve this with breakout sessions and global conference support. While other universities rely on Teams, the UFS’ user-friendly tech, with around 24 screens and ceiling microphones, allows lecturers to focus on teaching.

Staying ahead of tech trends is challenging, but the university is excelling, making education inclusive, engaging, and truly global.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept